Calculations of the binding free energies of the Comprehensive in vitro Proarrhythmia Assay (CiPA) reference drugs to cardiac ion channels
The evaluation of the inhibitory activities of drugs on multiple cardiac ion channels is required for the accurate assessment of proarrhythmic risks. Moreover, the in silico prediction of such inhibitory activities of drugs on cardiac channels can improve the efficiency of the drug-development proce...
Main Authors: | Tatsuki Negami, Tohru Terada |
---|---|
Format: | Article |
Language: | English |
Published: |
The Biophysical Society of Japan
2023-04-01
|
Series: | Biophysics and Physicobiology |
Subjects: | |
Online Access: | https://doi.org/10.2142/biophysico.bppb-v20.0016 |
Similar Items
-
General principles for the validation of proarrhythmia risk prediction models: an extension of the CiPA in silico strategy
by: Li, Z, et al.
Published: (2019) -
Assessment of the proarrhythmic effects of repurposed antimalarials for COVID-19 treatment using a comprehensive in vitro proarrhythmia assay (CiPA)
by: Seung-Hyun Yoon, et al.
Published: (2023-08-01) -
Testing the nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm with an established anti‐seizure medication: Levetiracetam case study
by: Annie Delaunois, et al.
Published: (2023-02-01) -
Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off‐label in the first wave of COVID‐19
by: Delaunois, A, et al.
Published: (2021) -
Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off‐label in the first wave of COVID‐19
by: Annie Delaunois, et al.
Published: (2021-05-01)